Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia

Anthracyclines constitute the backbone of intensive adult acute myeloid leukemia (AML) therapy. Cardiotoxicity is one of its most serious adverse effects, and its incidence increases with cumulative dose. Dexrazoxane is a cardioprotective agent used in conjunction with anthracycline therapy. There i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Res Rep
Main Authors: Vachhani, Pankit, Shin, Sarah, Baron, Jeffrey, Thompson, James E., Wetzler, Meir, Griffiths, Elizabeth A., Ontiveros, Evelena P., Spangenthal, Edward J., Wang, Eunice S.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Full Length Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5402627/
https://ncbi.nlm.nih.gov/pubmed/28462084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2017.04.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados